Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 18100 | 504 | 37.5 | 71% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 645 | 12871 | MAMMOGRAPHIC DENSITY//BREAST DENSITY//CANCER CAUSES & CONTROL |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | NUTR HORMONES UNIT | Address | 8 | 75% | 1% | 6 |
| 2 | ENDOMETRIAL CANCER RISK | Author keyword | 7 | 64% | 1% | 7 |
| 3 | ENDOMETRIAL NEOPLASMS | Author keyword | 7 | 15% | 9% | 43 |
| 4 | NM HLTH SCI | Address | 6 | 71% | 1% | 5 |
| 5 | CORPUS UTERI CANCER | Author keyword | 1 | 38% | 1% | 3 |
| 6 | HUMAN NUTR RHONE ALPES | Address | 1 | 38% | 1% | 3 |
| 7 | CANCER OF THE CORPUS UTERI | Author keyword | 1 | 50% | 0% | 2 |
| 8 | DR LUIS TISNE HOSP | Address | 1 | 100% | 0% | 2 |
| 9 | RISK PRAISAL PREVENT BRANCH | Address | 1 | 40% | 0% | 2 |
| 10 | ER120 | Address | 1 | 33% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | WEIGHT HISTORY | 7 | 67% | 1% | 6 |
| 2 | LAST DELIVERY | 6 | 100% | 1% | 4 |
| 3 | ANIMAL FOODS | 4 | 46% | 1% | 6 |
| 4 | ENDOGENOUS HORMONES | 4 | 15% | 4% | 22 |
| 5 | NATIONWIDE CASE CONTROL | 3 | 43% | 1% | 6 |
| 6 | VEIN BLOOD | 2 | 67% | 0% | 2 |
| 7 | STROMAL HYPERPLASIA | 2 | 33% | 1% | 4 |
| 8 | FREE ESTRADIOL | 1 | 23% | 1% | 3 |
| 9 | CORPUS UTERI | 1 | 14% | 1% | 5 |
| 10 | DIFFERENT ANATOMIC SITES | 1 | 50% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The effect of body mass index on endometrial cancer: a meta-analysis | 2015 | 1 | 49 | 65% |
| Physical activity and endometrial cancer risk, a systematic review of current evidence | 2007 | 47 | 31 | 65% |
| Physical activity, sedentary behaviours, and the prevention of endometrial cancer | 2010 | 32 | 25 | 60% |
| Age at Last Birth in Relation to Risk of Endometrial Cancer: Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium | 2012 | 5 | 37 | 65% |
| Reproductive Factors and the Risk of Endometrial Cancer | 2014 | 4 | 32 | 50% |
| Understanding obesity and endometrial cancer risk: opportunities for prevention | 2011 | 37 | 73 | 21% |
| Endometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorship | 2009 | 90 | 41 | 15% |
| Obesity, endogenous hormones, and endometrial cancer risk: A synthetic review | 2002 | 427 | 204 | 15% |
| Insulin resistance: A significant risk factor of endometrial cancer | 2012 | 27 | 96 | 17% |
| Coffee drinking and endometrial cancer risk: a metaanalysis of observational studies | 2009 | 20 | 35 | 40% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NUTR HORMONES UNIT | 8 | 75% | 1.2% | 6 |
| 2 | NM HLTH SCI | 6 | 71% | 1.0% | 5 |
| 3 | HUMAN NUTR RHONE ALPES | 1 | 38% | 0.6% | 3 |
| 4 | DR LUIS TISNE HOSP | 1 | 100% | 0.4% | 2 |
| 5 | RISK PRAISAL PREVENT BRANCH | 1 | 40% | 0.4% | 2 |
| 6 | ER120 | 1 | 33% | 0.4% | 2 |
| 7 | MED BRANCH MED | 1 | 33% | 0.4% | 2 |
| 8 | ALMATY ONCOL | 1 | 50% | 0.2% | 1 |
| 9 | CANC TREATMENT DIAGN | 1 | 50% | 0.2% | 1 |
| 10 | CHRISTIE NHS FDN TRUST CANC ENABLING SCI | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000217946 | ENDOMETRIAL HYPERPLASIA//ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA//ATYPICAL ENDOMETRIAL HYPERPLASIA |
| 2 | 0.0000161458 | FERTILITY DRUGS//OVARIAN NEOPLASMS//INCESSANT OVULATION |
| 3 | 0.0000147637 | CEITOX//BREAST CELL CARCINOGENESIS//POL III GENES |
| 4 | 0.0000135766 | REPRODUCTIVE FACTORS//AGE AT FIRST FULL TERM PREGNANCY//AGE AT LAST BIRTH |
| 5 | 0.0000132437 | PLASMA SPRAYED TITANIUM IMPLANTS//REMOVAL TORQUE TEST//CIGARETTE SMOKE MEDIUM |
| 6 | 0.0000107238 | ENDOMETRIAL CANCER//ENDOMETRIAL CARCINOMA//UTERINE PAPILLARY SEROUS CARCINOMA |
| 7 | 0.0000101322 | SVFP//ECREIN//ADIPOR2 |
| 8 | 0.0000097018 | METFORMIN//ANTIDIABETIC BIGUANIDES//GLARGINE |
| 9 | 0.0000087279 | PROLIFERATIVE BBD//STUDIES CULTURE SOC//WORLDWIDE SAFETY RISK MANAGEMENT |
| 10 | 0.0000085557 | ENDOMETRIAL SAFETY//TRIMEGESTONE//CAS 53 16 7 |